Simultaneous medullary and papillary thyroid cancer: a novel entity?

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• The etiology of concurrent medullary thyroid cancer (MTC) and papillary thyroid cancer (PTC) remains poorly understood.
• Simultaneous MTC and PTC represent an uncommon presentation of thyroid malignancies.

Purpose of the Study:

• To investigate the clinical and histopathologic characteristics of patients with simultaneous MTC and PTC.
• To identify trends associated with this dual diagnosis in a German tertiary referral center.

Main Methods:

• Retrospective analysis of 26 patients diagnosed with both MTC and PTC.
• Comparison of tumor characteristics and incidence rates with non-simultaneous cases.
• Genetic analysis for RET mutations in hereditary MTC cases.

Main Results:

• Simultaneous MTC and PTC occurred in 2.6% of PTC patients and 3.6% of MTC patients.
• Tumors in simultaneous cases were significantly smaller than non-simultaneous MTC and PTC.
• Incidence of simultaneous MTC and PTC increased over time, particularly for sporadic MTC.
• RET mutations were identified in 5 out of 6 patients with simultaneous hereditary MTC and PTC.

Conclusions:

• Increased diagnostic scrutiny and potential environmental factors contribute to the rising incidence of simultaneous MTC and PTC.
• The findings suggest a need for broader geographic and population-based studies to elucidate contributing factors.
• Smaller tumor size in simultaneous cases warrants further investigation into potential biological differences.